EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluating a virtual paediatric adverse drug reaction clinic

Emily Hauck, Blanca Del Pozzo-Magana, Michael Rieder iD

British Journal of Clinical Pharmacology · 24.05.2026

DOI: 10.1002/bcp.70616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 24.05.2026. Verfasst von Emily Hauck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric Clinical Pharmacology, Department of Paediatrics, University of Western Ontario, London, Ontario, Canada. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management. The purpose of this study was to evaluate the real world experience of, and satisfaction with, a virtual paediatric ADR clinic based in London, Canada during the COVID‐19 pandemic.

Methods

This was done using a mixed methods approach with a retrospective chart review from an online database and satisfaction surveys with patient families and referring clinicians.

Results

We found that 225 ADRs were assessed virtually over 3 years, with an average referral time of 23 days and 43.6% of patients residing in distant rural and urban communities. Further testing (most commonly DPT, RAST, and LTA) was recommended for 89.3% of patients. Whereas a number of results were pending, 17.2% and 43.5% of tests ordered were positive and negative, respectively, demonstrating success in allergy de‐labelling. A high level of satisfaction was reported by patient families (95.0%) and referring physicians (93.3%) that responded to the survey.

Conclusions

This study demonstrated the ability of a virtual clinic in a real‐world setting to efficiently assess and triage children with suspected ADRs and suggests that telemedicine may be a feasible way to improve access to specialized ADR services for children.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionschildrendrug provocation testlymphocyte toxicity assaytelemedicinevirtual

Autor:innen und Institutionen

  • Division of Paediatric Clinical Pharmacology, Department of Paediatrics, University of Western Ontario, London, Ontario, Canada.

ORCID-Profile: Michael Rieder

Zitieren

APA

Hauck, E., Del Pozzo-Magana, B., & Rieder, M. (2026). Evaluating a virtual paediatric adverse drug reaction clinic. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70616

Vancouver

Hauck E, Del Pozzo-Magana B, Rieder M. Evaluating a virtual paediatric adverse drug reaction clinic. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70616

BibTeX
@article{Hauck2026,
  author = {Hauck, Emily and Del Pozzo-Magana, Blanca and Rieder, Michael},
  title = {Evaluating a virtual paediatric adverse drug reaction clinic},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70616}
}
Kostenlos starten →